Home Cart Sign in  
Chemical Structure| 189279-58-1 Chemical Structure| 189279-58-1

Structure of Delafloxacin
CAS No.: 189279-58-1

Chemical Structure| 189279-58-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Delafloxacin is a fluoroquinolone antibiotic used to treat serious skin infections.

Synonyms: ABT492; RX-3341; RX-3341J

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Delafloxacin

CAS No. :189279-58-1
Formula : C18H12ClF3N4O4
M.W : 440.76
SMILES Code : O=C(C1=CN(C2=NC(N)=C(F)C=C2F)C3=C(C=C(F)C(N4CC(O)C4)=C3Cl)C1=O)O
Synonyms :
ABT492; RX-3341; RX-3341J
MDL No. :MFCD09955301
InChI Key :DYDCPNMLZGFQTM-UHFFFAOYSA-N
Pubchem ID :487101

Safety of Delafloxacin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Pseudomonas aeruginosa 1, 4, 10 µg/mL 24 h To evaluate the antibacterial activity of Delafloxacin against multidrug-resistant Pseudomonas aeruginosa (MDR-Psa), it was found that Delafloxacin demonstrated significantly better antibacterial activity than comparator fluoroquinolones in a CF sputum time-kill model, particularly at lower simulated physiologic concentrations PMC10295321
Ureaplasma urealyticum 0.125-4 mg/mL Evaluate the in vitro activity of Delafloxacin against U. urealyticum, showing low MIC values (MIC90=4 mg/mL) PMC9241805
Ureaplasma parvum 0.031-4 mg/mL Not used Evaluate the in vitro activity of Delafloxacin against U. parvum, showing low MIC values (MIC90=2 mg/mL) PMC9241805
Mycoplasma hominis 0.031-1 mg/mL Not used Evaluate the in vitro activity of Delafloxacin against M. hominis, showing low MIC values (MIC90=1 mg/mL) PMC9241805
S. aureus biofilms 9 µg/ml 48 h Investigate the effect of Delafloxacin on antibiotic tolerance in S. aureus biofilms, showing significantly reduced bactericidal effect under arginine-deprived conditions. PMC11306626

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c mice Aerosol infection model of melioidosis Subcutaneous injection 30, 50, and 80 mg/kg body weight Four times daily for 21 days To evaluate the efficacy of Delafloxacin in an aerosol infection model of melioidosis, results showed survival rates of 90% to 100% in the 50 and 80 mg/kg dose groups and 70% in the 30 mg/kg dose group. No detectable B. pseudomallei was found in the spleens of all Delafloxacin-treated cohorts at the end of the study. PMC8448139

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02245243 Hepatic Impairment PHASE1 COMPLETED 2025-02-15 Melinta 112 Study Site, Miami,... More >> Florida, 33136, United States|Melinta 112 Study Site, Orlando, Florida, 32809, United States Less <<
NCT03534622 Pneumonia PHASE1 COMPLETED 2018-07-27 Pulmonary Associates, Phoenix,... More >> Arizona, 85006, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.27mL

0.45mL

0.23mL

11.34mL

2.27mL

1.13mL

22.69mL

4.54mL

2.27mL

References

 

Historical Records

Categories